Russian Research Center Vector has Completed Preclinical Trials of a Vaccine against Coronavirus

14 July 2020

GMP News

Russia’s Vektor State Research Center for Virology and Biotechnologies has successfully completed pre-clinical trials of an anti-coronavirus vaccine, Anna Popova, chief of the Russian sanitary watchdog, said on July 10.

Colleagues have finished pre-clinical trials. They were successful. Actually, we have practically all the grounds to be sure that things will go as we promised, i.e. We plan to begin clinical trials on july 15,” she said in an interview with the vesti news program on the rossiya-1 television channel.

Russian Deputy Prime Minister Tatiana Golikova said earlier that works on the development of an anti-coronavirus vaccine proceeded as scheduled.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more